Serge Saxonov - 14 Mar 2023 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Issuer symbol
TXG
Transactions as of
14 Mar 2023
Net transactions value
-$97,756
Form type
4
Filing time
16 Mar 2023, 16:27:54 UTC
Previous filing
09 Mar 2023
Next filing
23 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $82,824 -1,697 -0.2% $48.81 863,708 14 Mar 2023 Direct F1, F2, F3
transaction TXG Class A Common Stock Sale $14,932 -303 -0.04% $49.28 863,405 14 Mar 2023 Direct F1, F4
holding TXG Class A Common Stock 870 14 Mar 2023 See footnote F5, F6
holding TXG Class A Common Stock 183,350 14 Mar 2023 See footnote F7
holding TXG Class A Common Stock 16,320 14 Mar 2023 See footnote F8
holding TXG Class A Common Stock 487 14 Mar 2023 See footnote F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $48.15 to $49.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 Excludes 870 shares transferred to Sirius Trust, 6,050 shares transferred to Y/S Pot Trust and 37,390 shares transferred to the Y/S Descendants' Trust, on March 11, 2023.
F4 This transaction was executed in multiple trades at prices ranging from $49.15 to $49.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 Excludes 870 shares transferred to Y/S Pot Trust on March 11, 2023.
F6 The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F7 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F8 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
F9 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.